Evolus Executives Sell Shares Amid Ongoing Market Volatility.

Evolus, Inc. [EOLS] has disclosed that Chief Medical Officer and Head of Research & Development, Avelar Rui, sold 29,996 shares at $4.89 per share on March 17, 2026. Additionally, Director, President, and Chief Executive Officer, Moatazedi David, sold 116,720 shares at $4.89 per share on the same date.